These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 23795353)

  • 1. [Prognostic value of tumor-infiltrating immune cells in melanoma].
    Ladányi A
    Magy Onkol; 2013 Jun; 57(2):85-95. PubMed ID: 23795353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma.
    Ladányi A
    Pigment Cell Melanoma Res; 2015 Sep; 28(5):490-500. PubMed ID: 25818762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Function and prognostic significance of immune cells infiltrating human tumors].
    Ladányi A
    Magy Onkol; 2004; 48(1):49-56. PubMed ID: 15105896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor.
    Ladányi A; Kiss J; Somlai B; Gilde K; Fejos Z; Mohos A; Gaudi I; Tímár J
    Cancer Immunol Immunother; 2007 Sep; 56(9):1459-69. PubMed ID: 17279413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotype and immunohistologic characteristics of tumor-infiltrating immune cells are associated with clinical outcome in metastatic melanoma.
    Erdag G; Schaefer JT; Smolkin ME; Deacon DH; Shea SM; Dengel LT; Patterson JW; Slingluff CL
    Cancer Res; 2012 Mar; 72(5):1070-80. PubMed ID: 22266112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic impact of B-cell density in cutaneous melanoma.
    Ladányi A; Kiss J; Mohos A; Somlai B; Liszkay G; Gilde K; Fejös Z; Gaudi I; Dobos J; Tímár J
    Cancer Immunol Immunother; 2011 Dec; 60(12):1729-38. PubMed ID: 21779876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral neutrophils and plasmacytoid dendritic cells indicate poor prognosis and are associated with pSTAT3 expression in AJCC stage I/II melanoma.
    Jensen TO; Schmidt H; Møller HJ; Donskov F; Høyer M; Sjoegren P; Christensen IJ; Steiniche T
    Cancer; 2012 May; 118(9):2476-85. PubMed ID: 21953023
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Innate immunity in cutaneous melanoma.
    Mignogna C; Scali E; Camastra C; Presta I; Zeppa P; Barni T; Donato G; Bottoni U; Di Vito A
    Clin Exp Dermatol; 2017 Apr; 42(3):243-250. PubMed ID: 28052512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma.
    Hillen F; Baeten CI; van de Winkel A; Creytens D; van der Schaft DW; Winnepenninckx V; Griffioen AW
    Cancer Immunol Immunother; 2008 Jan; 57(1):97-106. PubMed ID: 17602225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunophenotypic characterization of human primary and metastatic melanoma infiltrating leukocytes.
    Bodey B; Bodey B; Siegel SE; Luck JV; Kaiser HE
    Anticancer Res; 1996; 16(6B):3439-46. PubMed ID: 9042204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skin-test infiltrating lymphocytes early predict clinical outcome of dendritic cell-based vaccination in metastatic melanoma.
    Aarntzen EH; Bol K; Schreibelt G; Jacobs JF; Lesterhuis WJ; Van Rossum MM; Adema GJ; Figdor CG; Punt CJ; De Vries IJ
    Cancer Res; 2012 Dec; 72(23):6102-10. PubMed ID: 23010076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
    Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
    Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The avidity of tumor-specific T cells amplified by a plasmacytoid dendritic cell-based assay can predict the clinical evolution of melanoma patients.
    Charles J; Chaperot L; Revol B; Baudin M; Mouret S; Hamon A; Leccia MT; Plumas J; Aspord C
    Pigment Cell Melanoma Res; 2018 Jan; 31(1):82-94. PubMed ID: 28741900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ongoing adaptive immune responses in the microenvironment of melanoma metastases.
    van Baren N; Coulie PG
    Ann N Y Acad Sci; 2013 May; 1284():62-5. PubMed ID: 23651195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The predictive value of CD8, CD4, CD68, and human leukocyte antigen-D-related cells in the prognosis of cutaneous malignant melanoma with vertical growth phase.
    Piras F; Colombari R; Minerba L; Murtas D; Floris C; Maxia C; Corbu A; Perra MT; Sirigu P
    Cancer; 2005 Sep; 104(6):1246-54. PubMed ID: 16078259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of microvessel density with infiltrating cells in human cutaneous malignant melanoma.
    Kiss J; Tímár J; Somlai B; Gilde K; Fejôs Z; Gaudi I; Ladányi A
    Pathol Oncol Res; 2007; 13(1):21-31. PubMed ID: 17387385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulation and homing of melanoma-reactive T cells to both cutaneous and visceral metastases after vaccination with monocyte-derived dendritic cells.
    Berger TG; Haendle I; Schrama D; Lüftl M; Bauer N; Pedersen LØ; Schuler-Thurner B; Hohenberger W; Straten Pt Pt; Schuler G; Becker JC
    Int J Cancer; 2004 Aug; 111(2):229-37. PubMed ID: 15197776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma.
    Ladányi A; Somlai B; Gilde K; Fejös Z; Gaudi I; Tímár J
    Clin Cancer Res; 2004 Jan; 10(2):521-30. PubMed ID: 14760073
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune Cell Composition in Human Non-small Cell Lung Cancer.
    Stankovic B; Bjørhovde HAK; Skarshaug R; Aamodt H; Frafjord A; Müller E; Hammarström C; Beraki K; Bækkevold ES; Woldbæk PR; Helland Å; Brustugun OT; Øynebråten I; Corthay A
    Front Immunol; 2018; 9():3101. PubMed ID: 30774636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-infiltrating immune cells as prognostic markers in oral squamous cell carcinoma: a systematic review and meta-analysis.
    Hadler-Olsen E; Wirsing AM
    Br J Cancer; 2019 Apr; 120(7):714-727. PubMed ID: 30808992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.